Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model.
Perinatal hypoxic ischemic encephalopathy (HIE) remains a major contributor of infant death and long-term disability worldwide. The role played by the complement system in this ischemia-reperfusion injury remains poorly understood. In order to better understand the role of complement activation and...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0257960 |
_version_ | 1818990347193155584 |
---|---|
author | Parvathi Kumar Pamela Hair Kenji Cunnion Neel Krishna Thomas Bass |
author_facet | Parvathi Kumar Pamela Hair Kenji Cunnion Neel Krishna Thomas Bass |
author_sort | Parvathi Kumar |
collection | DOAJ |
description | Perinatal hypoxic ischemic encephalopathy (HIE) remains a major contributor of infant death and long-term disability worldwide. The role played by the complement system in this ischemia-reperfusion injury remains poorly understood. In order to better understand the role of complement activation and other modifiable mechanisms of injury in HIE, we tested the dual-targeting anti-inflammatory peptide, RLS-0071 in an animal model of HIE. Using the well-established HIE rat pup model we measured the effects of RLS-0071 during the acute stages of the brain injury and on long-term neurocognitive outcomes. Rat pups subject to hypoxia-ischemia insult received one of 4 interventions including normothermia, hypothermia and RLS-0071 with and without hypothermia. We measured histopathological effects, brain C1q levels and neuroimaging at day 1 and 21 after the injury. A subset of animals was followed into adolescence and evaluated for neurocognitive function. On histological evaluation, RLS-0071 showed neuronal protection in combination with hypothermia (P = 0.048) in addition to reducing C1q levels in the brain at 1hr (P = 0.01) and at 8 hr in combination with hypothermia (P = 0.005). MRI neuroimaging demonstrated that RLS-0071 in combination with hypothermia reduced lesion volume at 24 hours (P<0.05) as well as decreased T2 signal at day 21 in combination with hypothermia (P<0.01). RLS-0071 alone or in combination with hypothermia improved both short-term and long-term memory. These findings suggest that modulation by RLS-0071 can potentially decrease brain damage resulting from HIE. |
first_indexed | 2024-12-20T19:52:55Z |
format | Article |
id | doaj.art-632e0da05f98427c83b68800875cdff9 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-20T19:52:55Z |
publishDate | 2021-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-632e0da05f98427c83b68800875cdff92022-12-21T19:28:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01169e025796010.1371/journal.pone.0257960Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model.Parvathi KumarPamela HairKenji CunnionNeel KrishnaThomas BassPerinatal hypoxic ischemic encephalopathy (HIE) remains a major contributor of infant death and long-term disability worldwide. The role played by the complement system in this ischemia-reperfusion injury remains poorly understood. In order to better understand the role of complement activation and other modifiable mechanisms of injury in HIE, we tested the dual-targeting anti-inflammatory peptide, RLS-0071 in an animal model of HIE. Using the well-established HIE rat pup model we measured the effects of RLS-0071 during the acute stages of the brain injury and on long-term neurocognitive outcomes. Rat pups subject to hypoxia-ischemia insult received one of 4 interventions including normothermia, hypothermia and RLS-0071 with and without hypothermia. We measured histopathological effects, brain C1q levels and neuroimaging at day 1 and 21 after the injury. A subset of animals was followed into adolescence and evaluated for neurocognitive function. On histological evaluation, RLS-0071 showed neuronal protection in combination with hypothermia (P = 0.048) in addition to reducing C1q levels in the brain at 1hr (P = 0.01) and at 8 hr in combination with hypothermia (P = 0.005). MRI neuroimaging demonstrated that RLS-0071 in combination with hypothermia reduced lesion volume at 24 hours (P<0.05) as well as decreased T2 signal at day 21 in combination with hypothermia (P<0.01). RLS-0071 alone or in combination with hypothermia improved both short-term and long-term memory. These findings suggest that modulation by RLS-0071 can potentially decrease brain damage resulting from HIE.https://doi.org/10.1371/journal.pone.0257960 |
spellingShingle | Parvathi Kumar Pamela Hair Kenji Cunnion Neel Krishna Thomas Bass Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model. PLoS ONE |
title | Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model. |
title_full | Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model. |
title_fullStr | Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model. |
title_full_unstemmed | Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model. |
title_short | Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model. |
title_sort | classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model |
url | https://doi.org/10.1371/journal.pone.0257960 |
work_keys_str_mv | AT parvathikumar classicalcomplementpathwayinhibitionreducesbraindamageinahypoxicischemicencephalopathyanimalmodel AT pamelahair classicalcomplementpathwayinhibitionreducesbraindamageinahypoxicischemicencephalopathyanimalmodel AT kenjicunnion classicalcomplementpathwayinhibitionreducesbraindamageinahypoxicischemicencephalopathyanimalmodel AT neelkrishna classicalcomplementpathwayinhibitionreducesbraindamageinahypoxicischemicencephalopathyanimalmodel AT thomasbass classicalcomplementpathwayinhibitionreducesbraindamageinahypoxicischemicencephalopathyanimalmodel |